Saving your money for next purchases
Portrazza（Necitumumab）耐昔妥珠单抗
Necitumumab (INN: Necitumumab) is a recombinant human IgG1 monoclonal antibody used as an anti-tumor drug and produced by Eli Lilly and Company. It binds to the epidermal growth factor receptor (EGFR). The U.S. Food and Drug Administration approves nesituzumab (brand name Portrazza), along with gemcitabine and cisplatin, for the treatment of untreated metastatic squamous non-small cell lung cancer (NSCLC).
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
